Ohio State University Comprehensive Cancer Center at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
Ohio State University Comprehensive Cancer Center brings 2 presentations to ASH 2026 in New Orleans, and exhibits at Booth 2539. Its program centres on chronic lymphocytic leukemia and mantle cell lymphoma, with a focus on BTK inhibitors and treatment order after relapse. It also covers practical generative AI tools for clinicians and investigators, and AI for training program directors.
| Organization | ASH 2026 Attendance |
|---|---|
NCI-designated comprehensive cancer center of Ohio State University in Columbus, including its dedicated cancer hospital. | Booth Exhibiting at Booth 2539 Sat, Dec 1211:00am–5:00pmSun, Dec 1310:00am–5:00pmMon, Dec 1410:00am–2:00pm Symposium Fri Dec 11 7:00pm–10:00pm Cases and Conversations: Sequencing Strategies in Relapsed and Refractory CLL Continuous kinase inhibitors versus fixed-duration Bcl-2 combinations for chronic lymphocytic leukemia, weighed against recent phase 3 trial results. Symposium Fri Dec 11 11:00am–2:00pm CLL Challenge! Interrogating the Latest Evidence on Patient Priorities and Novel Targeted Therapies Shared decision-making in chronic lymphocytic leukemia, using biomarker testing to choose among fixed-duration, continuous, and newer targeted treatments. Symposium Fri Dec 11 11:00am–2:00pm Decoding High-Risk AML: Applying Molecular Insights to Clinical Decision-Making Using tests for isocitrate dehydrogenase and Flt3 mutations to guide targeted therapy choices in acute myeloid leukemia. Symposium Fri Dec 11 11:00am–2:00pm Realigning Modern Care in MCL: Guidance on the Next Wave of Advances With BTK Inhibitor Options and New Targeted Strategies Mantle cell lymphoma care built on Bruton tyrosine kinase inhibitors up front, with newer kinase and Bcl-2 inhibitors or CAR-T after relapse. Talk Practical Generative AI Tools for Clinicians and Investigators Using generative AI in hematology clinics and labs, from prompt writing to literature review, coding and data analysis, while protecting data privacy. Session Treating Fairly Rounds Lunch How hematologists and fellows can influence healthcare reform on research funding, Medicaid, and hospital budgets, and how policy shapes health inequities. |
Instantly find 20 buyers from Ohio State University Comprehensive Cancer Center
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction